Rifaximin's Effect on Covert Hepatic Encephalopathy in Cirrhosis Patients With Small Intestinal Bacterial Overgrowth and Gastrointestinal Dysmotility
Conditions:   Cirrhosis, Liver;   Minimal Hepatic Encephalopathy;   Small Intestinal Bacterial Overgrowth;   Gastrointestinal Motility Disorder Intervention:   Drug: Rifaximin Sponsor:   Ronnie Fass, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2020 Category: Research Source Type: clinical trials

Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit
Condition:   Cystic Fibrosis Gastrointestinal Disease Interventions:   Drug: Polyethylene Glycol 3350;   Device: SmartPill Motility System& PillCam Patency Capsule Sponsor:   St. Louis University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2019 Category: Research Source Type: clinical trials

Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility
Condition:   Dysautonomia Interventions:   Procedure: Celiac ganglion block;   Drug: Liposomal bupivacaine Sponsor:   Johns Hopkins University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

The Role of Pregnancy-induced Gallbladder Dysmotility in the Pathophysiology of Gestational Diabetes Mellitus
Condition:   Gestational Diabetes Mellitus Intervention:   Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2019 Category: Research Source Type: clinical trials